Mizuho Initiates Coverage On Minimed Group with Outperform Rating, Announces Price Target of $21

Mizuho analyst Anthony Petrone has initiated coverage on Minimed Group (NASDAQ: MMED) with an Outperform rating. The firm has set a price target of $21 for the stock.